Erika Vacchelli

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Topics

Dendritic Cells

Inflammatory Response

Endoplasmic Reticulum

Top Venues

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Julie Le Naour, Zsófia M Sztupinszki, Vincent Carbonnier, Odile Casiraghi, Virginie Marty, Lorenzo Galluzzi, Zoltan Szallasi, Guido Kroemer, Erika Vacchelli
A loss-of-function polymorphism in ATG16L1 compromises therapeutic outcome in head and neck carcinoma patients. Oncoimmunology 11 (1) (2022)
Zsófia M Sztupinszki, Julie Le Naour, Erika Vacchelli, Pierre Laurent-Puig, Suzette Delaloge, Zoltan Szallasi, Guido Kroemer
A major genetic accelerator of cancer diagnosis: rs867228 in FPR1. Oncoimmunology 10 (1) (2021)
Adriana Petrazzuolo, Julie Le Naour, Erika Vacchelli, Pascale Gaussem, Syrine Ellouze, Georges Jourdi, Eric Solary, Michaela Fontenay, David M Smadja, Guido Kroemer
No impact of cancer and plague-relevant FPR1 polymorphisms on COVID-19. Oncoimmunology 9 (1) (2020)
Julie Le Naour, Laurence Zitvogel, Lorenzo Galluzzi, Erika Vacchelli, Guido Kroemer
Trial watch: STING agonists in cancer therapy. Oncoimmunology 9 (1) (2020)
Giorgio Frega, Qi Wu, Julie Le Naour, Erika Vacchelli, Lorenzo Galluzzi, Guido Kroemer, Oliver Kepp
Trial Watch: experimental TLR7/TLR8 agonists for oncological indications. Oncoimmunology 9 (1) (2020)
Julie Le Naour, Lorenzo Galluzzi, Laurence Zitvogel, Guido Kroemer, Erika Vacchelli
Trial watch: IDO inhibitors in cancer therapy. Oncoimmunology 9 (1) (2020)
Julie Le Naour, Peng Liu, Liwei Zhao, Sandy Adjemian, Zsofia Sztupinszki, Julien Taieb, Claire Mulot, Aymeric Silvin, Charles-Antoine Dutertre, Florent Ginhoux, Allan Sauvat, Giulia Cerrato, Francesca Castoldi, Isabelle Martins, Gautier Stoll, Juliette Paillet, Khady Mangane, Cornelia Richter, Oliver Kepp, Maria Chiara Maiuri, Federico Pietrocola, Peter Vandenabeele, Fabrice Andre, Suzette Delaloge, Zoltan Szallasi, Pierre Laurent-Puig, Jessica Zucman-Rossi, Laurence Zitvogel, Jonathan G Pol, Erika Vacchelli, Guido Kroemer
A TLR3 Ligand Reestablishes Chemotherapeutic Responses in the Context of FPR1 Deficiency. Cancer discovery 11 (2) (2020)